Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by NorthStarron Jun 15, 2010 5:17pm
452 Views
Post# 17191657

RE: RE: RE: Something wierd on TD

RE: RE: RE: Something wierd on TDLoki,

Just had a chance to look on my Waterhouse account and I to show....


Market Cap 13.8M Beta -0.34
Revenue (FYR) -- EPS (TTM)
.05
Shares Out. 153.0M Book Value
.03
Stem Cell Therapeutics Corp does not pay a dividend. P/E 1.8x
Price/Sales (FYR) 0.0
P/Cash Flow (TTM) --
Operating Margin 0.00%


Non-Operating Income & Expenses   for 2009
Investment income 20
Pre-tax income 4,657


I don't understand myself on how Waterhouse can show EPS as 0.05 and Questrader can show it as -0.03 and then there is the Globe and Mail showing -0.05 EPS.

That is a big difference between the three. Guess you were not seeing things this morning :-)

North
Bullboard Posts